Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on X:
“Huge congrats to the brilliant and amazing Steven H. Lin and team on their stunning new Nature paper! From MD Anderson Cancer Center with Adam Grippin: SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade. Nature! Wow!”
Title: SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
Authors: Adam J. Grippin, Christiano Marconi, Sage Copling, Nan Li, Chen Braun, Cole Woody, Elliana Young, Priti Gupta, Min Wang, Annette Wu, Seong Dong Jeong, Dhruvkumar Soni, Frances Weidert, Chao Xie, Eden Goldenberg, Andrew Kim, Chong Zhao, Anna DeVries, Paul Castillo, Rishabh Lohray, Michael K. Rooney, Benjamin R. Schrank, Yifan Wang, Yifan Ma, Enoch Chang, Ramez Kouzy, Kyle Dyson, Jordan Jafarnia, Nina Nariman, Gregory Gladish, Jacob New, Ada Argueta, Diana Amaya, Nagheme Thomas, Andria Doty, Joe Chen, Nikhil Copling, Gabriel Alatrash, Julie Simon, Alicia Bea Davies, William Dennis, Richard Liang, Jeff Lewis, Xiong Wei, Waree Rinsurongkawong, Ara A. Vaporciyan, Andrew Johns, Jack Lee, Ji-Hyun Lee, Ryan Sun, Padmanee Sharma, Hai Tran, Jianjun Zhang, Don L. Gibbons, Jennifer Wargo, Betty Y. S. Kim, John V. Heymach, Hector R. Mendez-Gomez, Wen Jiang, Elias J. Sayour, Steven H. Lin
You can read the full article on Nature.
More posts featuring Vivek Subbiah.